AzTrials
AzTrials

BurnsNCT04530279

Clinical Assessment of Burns in Norway

An observational study of Burns, run by Haukeland University Hospital at 1 site in Norway.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Clinical assessment of burn depth and area can be challenging even for experienced surgeons. Still, the assessment is fundamental for the treatment, as it determines the fluid treatment and indication for escharotomy and need for referral to a burn centre.There are few studies comparing the initial evaluation of burn… Read more about this study

Who is it for?
Any age
Conditions the study is for
Burns
What is being tested?
Clinical assessment
Type of treatment
Surgery or procedure
How many people
100 participants
Where
1 siteNorway
Study dates
1 Jan 2018to 30 Jun 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: The cohort was defined as patients transferred to the burn unit at Haukeland university hospital during 2014.The incidence of burns in Norway is 15.5 /100 000/ year (pop. 5.2 mill), and 70-100 patients a year is treated at the national burn centre. The Australian and New Zealand Burn Association (ANZBA) referral criteria are used: * Burns > 10% Total Body Surface Area (TBSA) * Burns > 5% TBSA in children * Full Thickness burns > 5% TBSA * Burns of Special Areas - Face, Hands, Feet, Genitalia, Perineum, Major Joints and circumferential limb or chest burns * Burns with inhalation injury * Electrical burns * Chemical burns * Burns with pre-existing illness * Burns associated with major trauma * Burns at the extremes of age - young children and the elderly * Burn injury in pregnant women * Non-accidental burns

Who may be able to join

  • Patients transferred to the burn unit at Haukeland university hospital during 2014

Who cannot join

  • Readmissions
  • Patients transported to Haukeland directly from the site of the accident

Trial locations and contacts

1 site in 1 country.

Norway1 site, 1 recruiting
  • Haukeland University Hospital

    Bergen, Vestland, 5021

    Ragnvald L Brekke, MD, +47 40874208, ragnvald.ljones.brekke@helse-bergen.no

    Recruiting

Other trials in Norway

About this study

Official title: Accordance of Clinical Assessment of Burn Depth and %TBSA Between Referring Hospitals and the National Norwegian Burn Centre

Clinical assessment of burn depth and area can be challenging even for experienced surgeons. Still, the assessment is fundamental for the treatment, as it determines the fluid treatment and indication for escharotomy and need for referral to a burn centre.There are few studies comparing the initial evaluation of burn depth and surface with that of a specialist burn centre. The aim of this study was to make such a comparison for a cohort of patients admitted to a specialist burn centre during one year.The cohort was defined as patients transferred to the burn unit at Haukeland university hospital during 2014.

Conditions
Burns
Being tested
Clinical assessment
Keywords
clinical assessment, TBSA, national burn centre
Medical subject headings
Burns

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Clinical assessmentProcedure or surgery

    Clinical assessment of burn depth and the percentage of total body surface area (TBSA) burnt with any method

Study groups in NCT04530279
Study groupRoleWhat they receive
Referring hospitalBurn assessments performed in referring hospitals
Receives: Procedure: Clinical assessment
Burn centreBurn assessments performed in the national burn centre
Receives: Procedure: Clinical assessment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Burn depth

    Burn depth measured with any described clinical method.Clinical assessment of depth is a subjective evaluation based on visual and tactile characteristics, that is, wound appearance, capillary refill and wound sensibility to touch and pin prick.

    Measured: 1 year

  2. The percentage of total body surface area (TBSA) burnt

    TBSA measured with any described clinical method, for example, Wallace's Rule of Nines, Lund and Browder charts, and Palmar Surface Measurement ('rule of palm')

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Aug 2020
  2. Study start1 Jan 2018
  3. Primary completion31 Dec 2022 (estimated)
  4. Study completion30 Jun 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04530279
Sponsor's protocol ID
2014/1627, Rek-Vest
Status last verified
Mar 2022
First submitted
25 Aug 2020
Last updated
21 Mar 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Burns, run by Haukeland University Hospital at 1 site in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 21 Mar 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ragnvald L Brekke, MD (+4740874208, ragnvald.ljones.brekke@helse-bergen.no), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Burn depth (time frame: 1 year). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Mar 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in